These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 7909336
1. A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects. Reitz AB, Bennett DJ, Blum PS, Codd EE, Maryanoff CA, Ortegon ME, Renzi MJ, Scott MK, Shank RP, Vaught JL. J Med Chem; 1994 Apr 15; 37(8):1060-2. PubMed ID: 7909336 [No Abstract] [Full Text] [Related]
2. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents. Homan EJ, Copinga S, Elfström L, van der Veen T, Hallema JP, Mohell N, Unelius L, Johansson R, Wikström HV, Grol CJ. Bioorg Med Chem; 1998 Nov 15; 6(11):2111-26. PubMed ID: 9881101 [Abstract] [Full Text] [Related]
3. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors. Reitz AB, Baxter EW, Codd EE, Davis CB, Jordan AD, Maryanoff BE, Maryanoff CA, McDonnell ME, Powell ET, Renzi MJ, Schott MR, Scott MK, Shank RP, Vaught JL. J Med Chem; 1998 Jun 04; 41(12):1997-2009. PubMed ID: 9622541 [Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents. Hrib NJ, Jurcak JG, Huger FP, Errico CL, Dunn RW. J Med Chem; 1991 Mar 13; 34(3):1068-72. PubMed ID: 1672156 [Abstract] [Full Text] [Related]
10. Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics. Taverne T, Diouf O, Depreux P, Poupaert JH, Lesieur D, Guardiola-Lemaître B, Renard P, Rettori MC, Caignard DH, Pfeiffer B. J Med Chem; 1998 Jun 04; 41(12):2010-8. PubMed ID: 9622542 [Abstract] [Full Text] [Related]
12. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. Mohell N, Sällemark M, Rosqvist S, Malmberg A, Högberg T, Jackson DM. Eur J Pharmacol; 1993 Jul 06; 238(1):121-5. PubMed ID: 8405075 [Abstract] [Full Text] [Related]
13. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents. Norman MH, Rigdon GC, Hall WR, Navas F. J Med Chem; 1996 Mar 01; 39(5):1172-88. PubMed ID: 8676355 [Abstract] [Full Text] [Related]
14. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist. López-Rodríguez ML, Rosado ML, Benhamú B, Morcillo MJ, Sanz AM, Orensanz L, Beneitez ME, Fuentes JA, Manzanares J. J Med Chem; 1996 Oct 25; 39(22):4439-50. PubMed ID: 8893838 [Abstract] [Full Text] [Related]
16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation. Liao Y, Venhuis BJ, Rodenhuis N, Timmerman W, Wikström H, Meier E, Bartoszyk GD, Böttcher H, Seyfried CA, Sundell S. J Med Chem; 1999 Jun 17; 42(12):2235-44. PubMed ID: 10377229 [Abstract] [Full Text] [Related]